CI

At a glance

ClinicalIndex Comparison Record
Phase 1Completed· 57 enrolled
Drug / intervention
Ha44 +3 moredrug
Likely dose
Moxifloxacin 400mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01518699
NCT01518699Phase 1Completed
CompareCT.gov

A Randomized, Double-Blind, Placebo- and Active-Controlled Study to Evaluate the Effect of Ha44 Gel on the ECG in Healthy Adult Subjects

Dr. Reddy's Laboratories Limited·interventional·Posted Jan 26, 2012·Updated Jul 9, 2021

In Brief

A Phase 1 clinical trial evaluating Ha44, Ha44 Placebo, and 2 other interventions for Pediculosis. Completed, enrolled 57 participants across 1 site.

Detailed Summary

The purpose of this study is to Evaluate the Effect of Ha44 Gel on the Electrocardiogram in Healthy Volunteers.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPediculosis
CountriesUnited States
Collaborators--

Timeline

Phase 1CompletedFinished
201220132014201520162017201820192020202120222023202420252026
First PostedJan 26, 2012
Enrollment StartJan 1, 2012
Primary CompletionMay 1, 2012
TodayJul 2, 2026
Enrollment to primary: 4 monthsPosted 14.4 years ago

Interventions

Ha44drug

Abametapir Lotion 0.74%

Ha44 Placebodrug

Ha44 Vehicle Gel without Abametapir

Moxifloxacin Placebodrug

Moxifloxacin Placebo

Moxifloxacindrug

Moxifloxacin 400mg